Abingdon, United Kingdom

Vijaykumar Karuppiah

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunocore Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijaykumar Karuppiah. Retrieved from https://idiyas.com/inventor/vijaykumar-karuppiah-3dxkhmpd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Vijaykumar Karuppiah

Introduction

Vijaykumar Karuppiah is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that have potential applications in treating malignant diseases. His work exemplifies the intersection of scientific research and practical medical applications.

Latest Patents

Vijaykumar holds a patent for his invention titled "Binding molecules." This invention relates to binding molecules that comprise T cell receptor (TCR) variable domains, which can bind to a PIWIL1 peptide-HLA complex. The implications of this invention are profound, as it opens avenues for innovative treatments for various malignant diseases.

Career Highlights

Vijaykumar is currently associated with Immunocore Limited, a company that focuses on developing innovative therapies for cancer and other diseases. His role at Immunocore allows him to leverage his expertise in binding molecules to contribute to groundbreaking research and development in the field.

Collaborations

Some of his notable coworkers include Nicole Mai and Arnaud Techine. Their collaboration fosters a dynamic environment for innovation and enhances the potential for successful outcomes in their research endeavors.

Conclusion

Vijaykumar Karuppiah's work in binding molecules represents a significant advancement in the field of biotechnology. His contributions not only highlight his innovative spirit but also underscore the importance of collaboration in scientific research. His ongoing efforts at Immunocore Limited continue to pave the way for new therapeutic options in the fight against malignant diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…